What do the public think of preprints?
Get up to speed on why the general public struggle to understand preprint status.
What does the future hold for preprints: credibility vs accessibility?
Find out why measures to improve the credibility of preprints may be at odds with their core strengths.
The evolution of evaluation: Richard Sever on the future of peer review
Richard Sever talks about the future of peer review, the role of preprint servers, and how we might untangle research evaluation from research dissemination.
Can open access be made more equitable?
Read about inequities in terms of which researchers benefit most from open access and what could be done to help.
eLife’s ”˜reviewed preprint’ model: results from the first year
Find out what happened in the year since eLife ended accept/reject decisions in favour of ”˜reviewed preprints’.
Finding the way forward for peer review
Read about ways in which peer review could develop and diversify to keep up with modern research demands.
eLife shifts to publishing ”˜reviewed preprints’, ending accept/reject decisions
eLife hopes inclusion of open peer review reports and standardised assessments will help improve transparency and accessibility of research.
How common is data sharing for COVID-19 preprints?
An analysis of early COVID-19 preprints identified low uptake of data sharing statements and making data accessible.
How to encourage constructive public feedback on preprints?
ASAPbio summarise the newly developed FAST principles, a set of best practices to foster engagement in public preprint review.
An interview with Valérie Philippon: beyond clinical trial data
Valérie Philippon shares her perspectives on the value of including data beyond those generated in clinical trials in publication plans.